CTLA4 and neoplasm: Immune checkpoint inhibitors (ICIs) kill tumor cells by targeting immunosuppressive molecules expressed on immune cells, including cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), programmed cell death protein (PD-1), and its ligand PD-L1.2